Orphan Drugs: Portugal
Join industry executives in staying informed on the market access and HTA process in Portugal. 1. What is the definition of an orphan drug in your country? A medicinal product…
Join industry executives in staying informed on the market access and HTA process in Portugal. 1. What is the definition of an orphan drug in your country? A medicinal product shall be designated as an orphan medicinal product if its…
Join industry executives in staying informed on the market access and HTA process in Portugal. 1. What is the definition of an orphan drug in your country? A medicinal product…
Join industry executives in staying informed on the market access and HTA process in Portugal. 1. What is the definition of an orphan drug in your country? A medicinal product…
Join industry executives in staying informed on the market access and HTA process in Portugal. 1. What is the definition of an orphan drug in your country? A medicinal product…
1. Please describe the main cost containment policies in place in your country and their fundamental principles a. Pricing and impact of generic/biosimilar approval Currently there are no policies in place in this regard. b. Clawback/Payback/Discounts/Rebates In Portugal, the main mechanism for cost-containment is the prior evaluation, regulated by Decree-Law No. 97/2015 of June 1. The prior evaluation…
1. Please describe the main cost containment policies in place in your country and their fundamental principles a. Pricing and impact of generic/biosimilar approval Currently there are no policies…
1. Please describe the main cost containment policies in place in your country and their fundamental principles a. Pricing and impact of generic/biosimilar approval Currently there are no policies…
See our Cookie Privacy Policy Here